Regulus Secures $30 Million Growth Capital Credit Facility

LA JOLLA, Calif., June 20, 2016 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced it has entered in... Biopharmaceuticals, Venture CapitalRegulus Therapeutics, microRNA
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news